BDMD

Baird Medical Investment Holdings

Positive
Neutral
Negative
Sentiment 3-Months
Positive
Neutral 100%
Negative

Neutral
PRNewsWire
2 days ago
Baird Medical's MWA Technology Successfully Treats Large Thyroid Nodules at UCSF Health
NEW YORK , Oct. 16, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a global leader in minimally invasive Microwave Ablation (MWA) technology, announced its system was successfully used in two minimally invasive procedures at UCSF Health.
Baird Medical's MWA Technology Successfully Treats Large Thyroid Nodules at UCSF Health
Neutral
PRNewsWire
4 days ago
Baird Medical Highlights Johns Hopkins University Research Demonstrating Clinical and Economic Benefits of Thyroid Nodule Ablation
NEW YORK , Oct. 14, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("BAIRD MEDICAL" or the "Company"), a global leader in minimally invasive Microwave Ablation (MWA) technology, highlighted the significant findings of a cost-utility analysis conducted by researchers at Johns Hopkins University.
Baird Medical Highlights Johns Hopkins University Research Demonstrating Clinical and Economic Benefits of Thyroid Nodule Ablation
Neutral
PRNewsWire
9 days ago
Baird Medical Concludes Successful Participation at ACS Clinical Congress 2025 with Strong Interest in MWA Technology
NEW YORK , Oct. 9, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a global leader in minimally invasive Microwave Ablation (MWA) technology, has successfully concluded its participation in the American College of Surgeons (ACS) Clinical Congress 2025, held from October 5-7.
Baird Medical Concludes Successful Participation at ACS Clinical Congress 2025 with Strong Interest in MWA Technology
Neutral
PRNewsWire
12 days ago
Baird Medical Showcases Advanced Microwave Ablation Technology at the 2025 ACS Clinical Congress
NEW YORK , Oct. 6, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a global leader in minimally invasive Microwave Ablation (MWA) technology, is participating in the American College of Surgeons (ACS) Clinical Congress 2025 in Chicago, IL.
Baird Medical Showcases Advanced Microwave Ablation Technology at the 2025 ACS Clinical Congress
Neutral
PRNewsWire
17 days ago
Baird Medical Advances Microwave Ablation Training at Leading U.S. Thyroid Centers
NEW YORK , Oct. 1, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a global leader in minimally invasive Microwave Ablation (MWA) technology, highlighted its recent series of sponsored physician training programs hosted at premier U.S. academic medical centers.
Baird Medical Advances Microwave Ablation Training at Leading U.S. Thyroid Centers
Neutral
PRNewsWire
19 days ago
Baird Medical Showcases Advanced Ablation Technology at 2025 American Thyroid Association Annual Meeting
NEW YORK , Sept. 29, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd.
Baird Medical Showcases Advanced Ablation Technology at 2025 American Thyroid Association Annual Meeting
Neutral
PRNewsWire
5 months ago
Baird Medical Engages Global Clinical Leaders at AAES 2025
NEW YORK , May 19, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a global leader in minimally invasive Microwave Ablation (MWA) technology, is pleased to announce its participation in the 45th Annual Meeting of the American Association of Endocrine Surgeons (AAES), taking place from May 17-19, 2025, at the Baird Center in Milwaukee, Wisconsin.
Baird Medical Engages Global Clinical Leaders at AAES 2025
Neutral
PRNewsWire
5 months ago
Baird Medical Advances Thyroid MWA Training and Academic Exchange with Leading Harvard Professor
NEW YORK , May 12, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a leader in Microwave Ablation (MWA) technology, recently hosted an advanced training session and academic exchange in New Orleans, reinforcing its commitment to clinical innovation and research collaboration in minimally invasive thyroid therapies.
Baird Medical Advances Thyroid MWA Training and Academic Exchange with Leading Harvard Professor
Neutral
PRNewsWire
5 months ago
Baird Medical to Participate in the AAES 2025 Annual Meeting
NEW YORK , May 6, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a global leader in minimally invasive Microwave Ablation (MWA) technology, is pleased to announce its participation in the 45th Annual Meeting of the American Association of Endocrine Surgeons (AAES), taking place May 17-19, 2025, at the Baird Center in Milwaukee, Wisconsin.
Baird Medical to Participate in the AAES 2025 Annual Meeting
Neutral
PRNewsWire
5 months ago
Baird Medical to Participate in COSM 2025 Conference
NEW YORK , May 5, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a global leader in minimally invasive Microwave Ablation (MWA) technology, is pleased to announce its participation in the 2025 Combined Otolaryngology Spring Meetings (COSM), taking place May 14-18, 2025, in New Orleans, Louisiana.
Baird Medical to Participate in COSM 2025 Conference